GSK announced that it is recalling the popular heartburn medication Zantac® in all markets worldwide.

The recall was quickly announced after the FDA reported finding “unacceptable” levels of a carcinogenic impurity called NDMA in the pills.

The recall involves prescription-only Zantac® medicines, including a syrup, an injection, and pills of 150 and 300 milligram (mg) dosages.

Over-the-counter 75-mg doses of brand-name Zantac® are made by a different drug-maker and are not included in the recall.

Several recalls have been issued for generic Zantac (ranitidine) and over-the-counter products that include ranitidine.

Novartis halted distribution of ranitidine last month. Walmart, Walgreens, CVS, and Rite Aid have also suspended sales of over-the-counter heartburn drugs containing ranitidine.

Source: GSK recalls popular heartburn drug Zantac globally after cancer scare

Posted by Daily Hornet

We aim to provide progressive news that covers politics and corporate wrongdoing. We have no corporate interests to serve. No hidden agenda. We’re here to bring you the news you need to know with a grassroots twist.